US Patent Issued to Apple on July 28 for "TCI indication based continuation of multiple-cell activation" (American, German Inventors)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,695,583, issued on July 28, was assigned to Apple Inc. (Cupertino, Calif.).

"TCI indication based continuation of multiple-cell activation" was invented by Qunfeng He (San Diego), Dietmar Gradl (Munich), Jie Cui (Cupertino, Calif.), Hongbo Yan (San Diego), Amir Farajidana (Cupertino, Calif.) and Yang Tang (Cupertino, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Systems and methods provide multiple cell activation. A user equipment (UE) receives, from a wireless network, a command to activate multiple cells simultaneously. In response, the UE initiates cell activation procedures for the multiple cells. The cell activation procedures include wait...